Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B S Roden

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Journal of Virology|May 11, 2018
Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human PapillomavirusJoshua W Wang, Wai Hong Wu, Tsui-Chin Huang, et al.
Journal of Virology|September 29, 2004
Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88Rongcun Yang, Francisco Martinez Murillo, Hengmi Cui, et al.
Virology|September 19, 2012
Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and speciesAlessandra Handisurya, Patricia M Day, Cynthia D Thompson, et al.
Journal of Virology|May 14, 2005
Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancerRongcun Yang, Cosette M Wheeler, Xiaojiang Chen, et al.
The Journal of Investigative Dermatology|June 12, 2013
Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomavirusesChristina Schellenbacher, Kihyuck Kwak, Dieter Fink, et al.
The American Journal of Pathology|December 20, 2008
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2Zhenhua Lin, Anna V Yemelyanova, Ratish Gambhira, et al.
Virology|September 17, 2011
A multimeric L2 vaccine for prevention of animal papillomavirus infectionsSubhashini Jagu, Nicole Malandro, Kihyuck Kwak, et al.
Journal of Ovarian Research|August 9, 2017
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinomaRosie T Jiang, Anna Yemelyanova, Deyin Xing, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2008
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2Hannah H Alphs, Ratish Gambhira, Balasubramanyam Karanam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulationsRongcun Yang, Francisco Martinez Murillo, Ken-Yu Lin, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Journal of Virology|May 11, 2018
Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human PapillomavirusJoshua W Wang, Wai Hong Wu, Tsui-Chin Huang, et al.
Journal of Virology|September 29, 2004
Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88Rongcun Yang, Francisco Martinez Murillo, Hengmi Cui, et al.
Virology|September 19, 2012
Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and speciesAlessandra Handisurya, Patricia M Day, Cynthia D Thompson, et al.
Journal of Virology|May 14, 2005
Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancerRongcun Yang, Cosette M Wheeler, Xiaojiang Chen, et al.
The Journal of Investigative Dermatology|June 12, 2013
Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomavirusesChristina Schellenbacher, Kihyuck Kwak, Dieter Fink, et al.
The American Journal of Pathology|December 20, 2008
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2Zhenhua Lin, Anna V Yemelyanova, Ratish Gambhira, et al.
Virology|September 17, 2011
A multimeric L2 vaccine for prevention of animal papillomavirus infectionsSubhashini Jagu, Nicole Malandro, Kihyuck Kwak, et al.
Journal of Ovarian Research|August 9, 2017
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinomaRosie T Jiang, Anna Yemelyanova, Deyin Xing, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2008
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2Hannah H Alphs, Ratish Gambhira, Balasubramanyam Karanam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulationsRongcun Yang, Francisco Martinez Murillo, Ken-Yu Lin, et al.
Pageof 14